V.G. Casabó

873 total citations
39 papers, 689 citations indexed

About

V.G. Casabó is a scholar working on Oncology, Pharmaceutical Science and Molecular Biology. According to data from OpenAlex, V.G. Casabó has authored 39 papers receiving a total of 689 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Oncology, 12 papers in Pharmaceutical Science and 8 papers in Molecular Biology. Recurrent topics in V.G. Casabó's work include Drug Transport and Resistance Mechanisms (15 papers), Drug Solubulity and Delivery Systems (10 papers) and Analytical Chemistry and Chromatography (8 papers). V.G. Casabó is often cited by papers focused on Drug Transport and Resistance Mechanisms (15 papers), Drug Solubulity and Delivery Systems (10 papers) and Analytical Chemistry and Chromatography (8 papers). V.G. Casabó collaborates with scholars based in Spain, Germany and United States. V.G. Casabó's co-authors include Marival Bermejo, Ana Ruiz-Garcı́a, Amparo Nácher, Aaron M. Moss, Isabel González‐Álvarez, Matilde Merino‐Sanjuán, Carlos Fernández‐Teruel, A. Martín‐Villodre, J.M. Plá-Delfina and M. Herráez and has published in prestigious journals such as Antimicrobial Agents and Chemotherapy, International Journal of Pharmaceutics and Pharmaceutical Research.

In The Last Decade

V.G. Casabó

39 papers receiving 678 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
V.G. Casabó Spain 17 212 195 168 134 88 39 689
Chyung S. Cook United States 13 268 1.3× 104 0.5× 200 1.2× 153 1.1× 171 1.9× 29 850
Shiyin Yee United States 9 213 1.0× 259 1.3× 447 2.7× 116 0.9× 141 1.6× 13 1.2k
Kin‐Kai Hwang United States 7 105 0.5× 194 1.0× 168 1.0× 65 0.5× 79 0.9× 16 528
Kimberley A. Lentz United States 14 323 1.5× 305 1.6× 199 1.2× 78 0.6× 125 1.4× 24 963
Bernard E. Cabana United States 16 144 0.7× 77 0.4× 200 1.2× 175 1.3× 95 1.1× 42 872
Aki T. Heikkinen Finland 18 211 1.0× 317 1.6× 215 1.3× 81 0.6× 236 2.7× 34 819
Edwin T. Sugita United States 15 228 1.1× 197 1.0× 164 1.0× 182 1.4× 79 0.9× 42 813
Stephen W.J. Wang United States 10 111 0.5× 151 0.8× 174 1.0× 97 0.7× 121 1.4× 11 590
Xavier Boulenc France 15 109 0.5× 303 1.6× 198 1.2× 78 0.6× 336 3.8× 19 814
Gloria Y. Kwei United States 14 214 1.0× 324 1.7× 339 2.0× 118 0.9× 348 4.0× 28 1.2k

Countries citing papers authored by V.G. Casabó

Since Specialization
Citations

This map shows the geographic impact of V.G. Casabó's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by V.G. Casabó with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites V.G. Casabó more than expected).

Fields of papers citing papers by V.G. Casabó

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by V.G. Casabó. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by V.G. Casabó. The network helps show where V.G. Casabó may publish in the future.

Co-authorship network of co-authors of V.G. Casabó

This figure shows the co-authorship network connecting the top 25 collaborators of V.G. Casabó. A scholar is included among the top collaborators of V.G. Casabó based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with V.G. Casabó. V.G. Casabó is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mangas‐Sanjuan, Víctor, Isabel González‐Álvarez, Alfredo García‐Arieta, et al.. (2015). Semi-physiologic model validation and bioequivalence trials simulation to select the best analyte for acetylsalicylic acid. European Journal of Pharmaceutical Sciences. 74. 86–94. 6 indexed citations
2.
Schaefer, Ulrich F., et al.. (2014). Statistical Comparison of Dissolution Profiles to Predict the Bioequivalence of Extended Release Formulations. The AAPS Journal. 16(4). 791–801. 11 indexed citations
3.
Fernández‐Teruel, Carlos, Víctor Mangas‐Sanjuan, Isabel González‐Álvarez, et al.. (2013). Mathematical modeling of oral absorption and bioavailability of a fluoroquinolone after its precipitation in the gastrointestinal tract. Xenobiotica. 43(9). 745–754. 5 indexed citations
4.
González‐Álvarez, Isabel, et al.. (2011). A new mathematical approach for the estimation of the AUC and its variability under different experimental designs in preclinical studies. Pharmaceutical Statistics. 11(1). 14–23. 5 indexed citations
5.
González‐Álvarez, Isabel, Marta González‐Álvarez, M.S. Manku, et al.. (2010). Influence of polyunsaturated fatty acids on Cortisol transport through MDCK and MDCK-MDR1 cells as blood–brain barrier in vitro model. European Journal of Pharmaceutical Sciences. 42(3). 290–299. 26 indexed citations
6.
González‐Álvarez, Isabel, et al.. (2010). Computer simulations for bioequivalence trials: Selection of analyte in BCS drugs with first-pass metabolism and two metabolic pathways. European Journal of Pharmaceutical Sciences. 41(5). 716–728. 9 indexed citations
7.
Lledó‐García, Rocío, Amparo Nácher, V.G. Casabó, & Matilde Merino‐Sanjuán. (2010). A Pharmacokinetic Model for Evaluating the Impact of Hepatic and Intestinal First-Pass Loss of Saquinavir in the Rat. Drug Metabolism and Disposition. 39(2). 294–301. 10 indexed citations
8.
Fernández‐Teruel, Carlos, Ricardo Nalda‐Molina, Isabel González‐Álvarez, et al.. (2008). Computer simulations of bioequivalence trials: Selection of design and analyte in BCS drugs with first-pass hepatic metabolism: Linear kinetics (I). European Journal of Pharmaceutical Sciences. 36(1). 137–146. 18 indexed citations
9.
Fernández‐Teruel, Carlos, et al.. (2008). Computer simulations of bioequivalence trials: Selection of design and analyte in BCS drugs with first-pass hepatic metabolism: Part II. Non-linear kinetics. European Journal of Pharmaceutical Sciences. 36(1). 147–156. 15 indexed citations
10.
Ruiz-Garcı́a, Ana, Marival Bermejo, Aaron M. Moss, & V.G. Casabó. (2007). Pharmacokinetics in Drug Discovery. Journal of Pharmaceutical Sciences. 97(2). 654–690. 127 indexed citations
11.
Merino‐Sanjuán, Matilde, et al.. (2006). Population modelling to describe pharmacokinetics of amiodarone in rats: Relevance of plasma protein and tissue depot binding. European Journal of Pharmaceutical Sciences. 30(2). 190–197. 7 indexed citations
12.
Lledó‐García, Rocío, et al.. (2006). Bioavailability and Pharmacokinetic Model for Ritonavir in the Rat. Journal of Pharmaceutical Sciences. 96(3). 633–643. 10 indexed citations
13.
Muñoz, Marı́a Jesús, et al.. (2005). Use of nonlinear mixed effect modeling for the intestinal absorption data: Application to ritonavir in the rat. European Journal of Pharmaceutics and Biopharmaceutics. 61(1-2). 20–26. 12 indexed citations
14.
Nácher, Amparo, et al.. (2002). Intestinal transport of cefuroxime axetil in rats: absorption and hydrolysis processes. International Journal of Pharmaceutics. 234(1-2). 101–111. 25 indexed citations
15.
Nácher, Amparo, et al.. (2000). Pharmacokinetics and absolute bioavailability of oral cefuroxime axetil in the rat. International Journal of Pharmaceutics. 202(1-2). 89–96. 16 indexed citations
16.
Casabó, V.G., et al.. (1997). INTESTINAL ABSORPTION KINETICS OF AMIODARONE IN RAT SMALL INTESTINE. Biopharmaceutics & Drug Disposition. 18(6). 523–532. 16 indexed citations
17.
Polache, Ana, et al.. (1995). Influence of leucine on intestinal baclofen absorption as a model compound of neutral α‐aminoacids. Biopharmaceutics & Drug Disposition. 16(7). 563–577. 16 indexed citations
18.
Merino‐Sanjuán, Matilde, et al.. (1994). Effects of Surfactants on Amiodarone Intestinal Absorption. I. Sodium Laurylsulfate. Pharmaceutical Research. 11(7). 1042–1047. 10 indexed citations
19.
Torres‐Molina, Francisca, et al.. (1989). Evidence of a specialized transport mechanism for the intestinal absorption of baclofen. Biopharmaceutics & Drug Disposition. 10(3). 279–297. 36 indexed citations
20.
Casabó, V.G., et al.. (1987). Studies on the reliability of a bihyperbolic functional absorption model. II. Phenylalkylamines. Journal of Pharmacokinetics and Biopharmaceutics. 15(6). 633–643. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Chyung S. Cook Breakdown of academic impact, for papers by Shiyin Yee Breakdown of academic impact, for papers by Kin‐Kai Hwang Breakdown of academic impact, for papers by Kimberley A. Lentz Breakdown of academic impact, for papers by Bernard E. Cabana Breakdown of academic impact, for papers by Aki T. Heikkinen Breakdown of academic impact, for papers by Edwin T. Sugita Breakdown of academic impact, for papers by Stephen W.J. Wang Breakdown of academic impact, for papers by Xavier Boulenc Breakdown of academic impact, for papers by Gloria Y. Kwei
Rankless by CCL
2026